D-0802-2021 Class II Terminated
FDA drug recall D-0802-2021 was initiated by Akorn, Inc. on Aug 13, 2021 and is designated Class II. Reason for recall: Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product. The recall status is terminated (terminated Aug 17, 2022). Affected quantity: 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 22, 2021
- Initiation Date
- Aug 13, 2021
- Termination Date
- Aug 17, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289
Product description
Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701
Reason for recall
Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.
Distribution pattern
USA Nationwide
Code information
Lot #: a) 372286, 372289, Exp 1/31/2022, b) 372286, 372289, Exp 1/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0802-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026